The Hidden Biases in Sickle Cell Care: Why Trust is a Matter of Life and Death
There’s a scene in The Pitt that’s stuck with me long after I finished watching it. A Black woman with sickle cell disease arrives at the ER in excruciating pain, only to be dismissed as a drug seeker. It’s a fictional portrayal, but it’s far from fiction. Personally, I think this scene captures a harsh reality that’s been swept under the rug for far too long. What makes this particularly fascinating—and deeply troubling—is how it mirrors real-life experiences of sickle cell patients, who are often met with skepticism, bias, and subpar care.
Sickle cell disease, a chronic condition primarily affecting Black individuals, is a perfect storm of intersectional biases. Race, chronic pain, and opioid use converge to create a healthcare environment where patients are frequently misunderstood, mistrusted, and mistreated. A recent study led by Dr. Austin Wesevich and Dr. Monica Peek at the University of Chicago Medicine sheds light on this issue, but what it reveals is both illuminating and infuriating.
The Language of Bias: What Clinician Notes Really Say
One thing that immediately stands out is the power of language in medical settings. The study analyzed over 40,000 clinician notes and found that patients with sickle cell disease were more likely to be described with negative terms like aggressive, noncooperative, or noncompliant. What many people don’t realize is that these words aren’t just descriptors—they’re judgments. They shape how clinicians perceive patients and, ultimately, how they treat them.
From my perspective, this is where the system fails. Clinicians are supposed to be impartial, yet their notes often reflect biases tied to race, pain management, and opioid use. For instance, the study found that sickle cell patients had similar odds of negative descriptors as those with opioid use disorder, even though the majority of sickle cell patients use opioids responsibly to manage chronic pain. This raises a deeper question: Are clinicians conflating legitimate pain management with drug-seeking behavior simply because of racial and societal stereotypes?
The Trust Gap: Why Pain is a Choice to Believe
Clinicians cannot measure pain objectively. It’s a subjective experience, and patients must be trusted to communicate their suffering accurately. But here’s the kicker: trust isn’t distributed equally. Dr. Wesevich points out that clinicians are often trained to look for physical signs of pain, like elevated heart rates or visible distress. But sickle cell patients, who experience daily pain, may not exhibit these signs. This creates a dangerous disconnect.
If you take a step back and think about it, this is where bias becomes life-threatening. A patient in acute pain who doesn’t “look” like they’re suffering is more likely to be dismissed, especially if they’re Black and requesting opioids. This isn’t just about poor bedside manner—it’s about systemic racism and the dehumanization of marginalized patients.
The Role of Intersectionality: Why It’s Hard to Pinpoint Discrimination
Dr. Peek highlights a critical point: many marginalized patients have multiple stigmatized identities. Race, chronic illness, and opioid use intersect in complex ways, making it difficult to isolate the root cause of discrimination. In my opinion, this complexity is both the problem and the opportunity. By acknowledging these intersections, we can begin to address biases more holistically.
What this really suggests is that anti-bias training must go beyond surface-level solutions. It’s not enough to tell clinicians to “be less biased.” They need tools to recognize how their own assumptions—about race, pain, and opioids—influence their decision-making.
A Glimmer of Hope: Anti-Bias Interventions in Action
Fortunately, the study isn’t just about identifying problems—it’s about solutions. The researchers developed an anti-bias curriculum that uses roleplay and education to challenge clinicians’ assumptions. Early results are promising, with nearly 70 residents at UChicago Medicine already participating.
A detail that I find especially interesting is the focus on trust. The curriculum emphasizes that believing patients about their pain isn’t just a moral imperative—it’s a medical one. This shift in mindset could be transformative, not just for sickle cell patients but for all marginalized groups who face skepticism in healthcare.
The Bigger Picture: Why This Matters Beyond Sickle Cell
This study isn’t just about sickle cell disease. It’s a wake-up call about the broader issues of bias and trust in healthcare. What’s happening to sickle cell patients is symptomatic of a system that devalues Black lives and criminalizes pain. If we can address these biases here, we can begin to dismantle them elsewhere.
In my opinion, the real challenge isn’t just changing clinician behavior—it’s changing the culture of medicine. We need to stop treating patients like problems to be solved and start treating them like people to be heard.
Final Thoughts: Trust as a Matter of Justice
As I reflect on this study, I’m struck by how much of healthcare hinges on trust. For sickle cell patients, that trust is often denied, with devastating consequences. But this research offers a path forward—one that acknowledges the problem, confronts it head-on, and works to fix it.
Personally, I think this is just the beginning. The work of Dr. Wesevich, Dr. Peek, and their team is a beacon of hope, but it’s also a call to action. We can’t afford to ignore the biases that harm patients. Trust isn’t just a nicety—it’s a matter of life and death. And it’s time we start treating it that way.
